Novel mutation in CTNNB1 causes familial exudative vitreoretinopathy (FEVR) and microcephaly: case report and review of the literature

References

• Criswick VG, Schepens CL. Familial exudative vitreoretinopathy. Am J Ophthalmol. 1969;68:578–94. doi:10.1016/0002-9394(69)91237-9.
   PubMed Web of Science ®Google Scholar
• Gilmour DF. Familial exudative vitreoretinopathy and related retinopathies. Eye. 2015;29:1–14. doi:10.1038/eye.2014.70.
   PubMed Web of Science ®Google Scholar
• Kashani AH, Brown KT, Chang E, Drenser KA, Capone A, Trese MT. Diversity of retinal vascular anomalies in patients with familial exudative vitreoretinopathy. Ophthalmology. 2014;121:2220–27. doi:10.1016/j.ophtha.2014.05.029.
   PubMed Web of Science ®Google Scholar
• Salvo J, Lyubasyuk V, Xu M, Wang H, Wang F, Nguyen D, Wang K, Luo H, Wen C, Shi C, et al. Next-generation sequencing and novel variant determination in a cohort of 92 familial exudative vitreoretinopathy patients. Invest Ophthalmol Vis Sci. 2015;56:1937–46.
   PubMed Web of Science ®Google Scholar
• Warden SM, Andreoli CM, Mukai S. The Wnt signaling pathway in familial exudative vitreoretinopathy and Norrie disease. Sem Ophthalmol. 2007;22:211–17. doi:10.1080/08820530701745124.
   PubMedGoogle Scholar
• Niehrs C, Acebron SP. Mitotic and mitogenic Wnt signalling. Embo J. 2012;31:2705–13. doi:10.1038/emboj.2012.124.
   PubMed Web of Science ®Google Scholar
• Panagiotou ES, Sanjurjo Soriano C, Poulter JA, Lord EC, Dzulova D, Kondo H, Hiyoshi A, Chung BH-Y, Chu -YW-Y, Lai CHY, et al. Defects in the cell signaling mediator beta-catenin cause the retinal vascular condition FEVR. Am J Hum Genet. 2017;100:960–68. doi:10.1016/j.ajhg.2017.05.001.
   PubMed Web of Science ®Google Scholar
• Dixon MW, Stem MS, Schuette JL, Keegan CE, Besirli CG. CTNNB1 mutation associated with familial exudative vitreoretinopathy (FEVR) phenotype. Ophthalmic Genet. 2016;37:468–70. doi:10.3109/13816810.2015.1120318.
   PubMed Web of Science ®Google Scholar
• Robitaille JM, Gillett RM, LeBlanc MA, Gaston D, Nightingale M, Mackley MP, Parkash S, Hathaway J, Thomas A, Ells A, et al. Phenotypic overlap between familial exudative vitreoretinopathy and microcephaly, lymphedema, and chorioretinal dysplasia caused by KIF11 mutations. JAMA Ophthalmol. 2014;132:1393–99.
   PubMed Web of Science ®Google Scholar
• Toomes C, Bottomley HM, Jackson RM, Towns KV, Scott S, Mackey DA, Craig JE, Jiang L, Yang Z, Trembath R, et al. Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q. Am J Hum Genet. 2004;74:721–30.
   PubMed Web of Science ®Google Scholar
• Qin M, Hayashi H, Oshima K, Tahira T, Hayashi K, Kondo H. Complexity of the genotype-phenotype correlation in familial exudative vitreoretinopathy with mutations in the LRP5 and/or FZD4 genes. Hum Mutat. 2005;26:104–12. doi:10.1002/humu.v26:2.
   PubMed Web of Science ®Google Scholar
• Nollet F, Berx G, Molemans F, van Roy F. Genomic organization of the human beta-catenin gene (CTNNB1). Genomics. 1996;32:413–24. doi:10.1006/geno.1996.0136.
   PubMed Web of Science ®Google Scholar
• Heuberger J, Birchmeier W. Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling. Cold Spring Harb Perspect Biol. 2010;2:a002915. doi:10.1101/cshperspect.a002915.
   PubMed Web of Science ®Google Scholar
• MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009;17:9–26. doi:10.1016/j.devcel.2009.06.016.
   PubMed Web of Science ®Google Scholar
• Jamieson C, Sharma M, Henderson BR. Wnt signaling from membrane to nucleus: b-catenin caught in a loop. Int J Biochem Cell Biol. 2012;44:847–50. doi:10.1016/j.biocel.2012.03.001.
   PubMed Web of Science ®Google Scholar
• Daneman R, Agalliu D, Zhou L, Kuhnert F, Kuo CJ, Barres BA. Wnt/beta-catenin signaling is required for CNS, but not non-CNS, angiogenesis. Proc Natl Acad Sci USA. 2009;106:641–46. doi:10.1073/pnas.0805165106.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Wang Y, Tischfield M, Williams J, Smallwood PM, Rattner A, Taketo MM, Nathans J. Canonical WNT signaling components in vascular development and barrier formation. J Clin Invest. 2014;124:3825–46. doi:10.1172/JCI76431.
   PubMed Web of Science ®Google Scholar
• Azmitia EC, Saccomano ZT, Alzoobaee MF, Boldrini M, Whitaker-Azmitia PM. Persistent angiogenesis in the autism brain: an immunocytochemical study of postmortem cortex, brainstem and cerebellum. J Autism Dev Disord. 2016;46:1307–18. doi:10.1007/s10803-015-2672-6.
   PubMed Web of Science ®Google Scholar
• Sun W, Xiao X, Li S, Jia X, Wang P, Zhang Q. Germline mutations in CTNNB1 associated with syndromic FEVR or Norrie disease. Invest Ophthalmol Vis Sci. 2019;60(1):93–97. doi:10.1167/iovs.18-25142.
   PubMed Web of Science ®Google Scholar
• De Silva TM, Faraci FM. Microvascular dysfunction and cognitive impairment. Cell Mol Neurobiol. 2016;36:241–58. doi:10.1007/s10571-015-0308-1.
   PubMed Web of Science ®Google Scholar
• Li N, Xu Y, Li G, Yu T, Yao RE, Wang X, Wang J. Exome sequencing identifies a de novo mutation of CTNNB1 gene in a patient mainly presented with retinal detachment, lens and vitreous opacities, microcephaly, and developmental delay: case report and literature review. Medicine (Baltimore). 2017;96:e6914. doi:10.1097/MD.0000000000006914.
   PubMed Web of Science ®Google Scholar
• Fu Y, Zheng S, An N, Athanasopoulos T, Popplewell L, Liang A, Li K, Hu C, Zhu Y. beta-catenin as a potential key target for tumor suppression. Int J Cancer. 2011;129:1541–51.
   PubMed Web of Science ®Google Scholar
• Anastas JN, Moon RT. WNT signaling pathways as therapeutic targets in cancer. Nat Rev Cancer. 2013;13:11–26. doi:10.1038/nrc3419.
   PubMed Web of Science ®Google Scholar
• Tucci V, Kleefstra T, Hardy A, Heise I, Maggi S, Willemsen MH, Hilton H, Esapa C, Simon M, Buenavista M-T, et al. Dominant beta-catenin mutations cause intellectual disability with recognizable syndromic features. J Clin Invest. 2014;124:1468–82.
   PubMed Web of Science ®Google Scholar
• Dubruc E, Putoux A, Labalme A, Rougeot C, Sanlaville D, Edery P. A new intellectual disability syndrome caused by CTNNB1 haploinsufficiency. Am J Med Genet Part A. 2014;164A:1571–75.
   PubMedGoogle Scholar
• Kuechler A, Willemsen MH, Albrecht B, Bacino CA, Bartholomew DW, van Bokhoven H, van den Boogaard MJ, Bramswig N, Büttner C, Cremer K, et al. De novo mutations in beta-catenin (CTNNB1) appear to be a frequent cause of intellectual disability: expanding the mutational and clinical spectrum.Human. Genet. 2015;134:97–109.
   Web of Science ®Google Scholar
• Kharbanda M, Pilz DT, Tomkins S, Chandler K, Saggar A, Fryer A, McKay V, Louro P, Smith JC, Burn J, et al. DDD Study. Clinical features associated with CTNNB1 de novo loss of function mutations in ten individuals. Eur J Med Genet. 2017;60:130–35.
   PubMed Web of Science ®Google Scholar